These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Allogeneic bone marrow transplantation for hypereosinophilic syndrome with advanced myelofibrosis. Sadoun A, Lacotte L, Delwail V, Randriamalala E, Patri S, Babin P, Brizard A, Guilhot F. Bone Marrow Transplant; 1997 Apr; 19(7):741-3. PubMed ID: 9156253 [Abstract] [Full Text] [Related]
3. Allogeneic blood stem cell transplantation following non-myeloablative conditioning for hypereosinophilic syndrome. Juvonen E, Volin L, Koponen A, Ruutu T. Bone Marrow Transplant; 2002 Mar; 29(5):457-8. PubMed ID: 11919738 [Abstract] [Full Text] [Related]
4. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation. Ciurea SO, Sadegi B, Wilbur A, Alagiozian-Angelova V, Gaitonde S, Dobogai LC, Akard LP, Hoffman R, Rondelli D. Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970 [Abstract] [Full Text] [Related]
10. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A, GITMO. Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030 [Abstract] [Full Text] [Related]
15. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report. Saikia TK, Parikh PM, Tawde S, Amare-Kadam PS, Rajadhyaksha S, Chhaya S. Natl Med J India; 2004 Dec; 17(2):71-3. PubMed ID: 15141598 [Abstract] [Full Text] [Related]
16. [CD34+ cell dose and hematologic recovery in allogeneic peripheral blood stem cell transplantation]. Sawada H, Wake A, Yamasaki Y, Izumi Y. Rinsho Ketsueki; 2000 Jun; 41(6):500-6. PubMed ID: 10921350 [Abstract] [Full Text] [Related]
17. [Secondary eosinophilia in a patient with hypereosinophilic syndrome after allogeneic bone marrow transplantation from a sibling donor]. Ito C, Tsuboi K, Yoshiba F, Kubota N, Tazume K, Oki M, Tsuchiya T, Ohmachi K, Kikuchi A, Shimakura Y, Ando K, Kishi K, Yonekura S, Hotta T. Rinsho Ketsueki; 2001 Jun; 42(6):496-501. PubMed ID: 11505529 [Abstract] [Full Text] [Related]
18. Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis. Ni H, Barosi G, Rondelli D, Hoffman R. Am J Clin Pathol; 2005 Jun; 123(6):833-9. PubMed ID: 15899773 [Abstract] [Full Text] [Related]
19. [Primary myelofibrosis successfully treated with allogeneic bone marrow transplantation]. Iwata N, Inoue N, Tamura A, Miyazaki E, Fujimori Y, Okamoto T, Takemoto Y, Kosaki M, Kanamaru A, Kakishita E. Rinsho Ketsueki; 1992 Nov; 33(11):1703-7. PubMed ID: 1469787 [Abstract] [Full Text] [Related]